The use of electronic health records (EHRs) does not guarantee a higher quality of care, just a higher quality of reporting, according to a meta-analysis of articles published in the Journal of Diabetes Science and Technology.

A National Health Service (NHS) hospital trust in the United Kingdom reduced home visits by using an AI-enabled wearable platform to remotely monitor patients recently released from the hospital, according to a case study.

The lifetime cumulative risk of sudden cardiac death (SCD) is much higher in black patients than in whites, according to an analysis of the Atherosclerosis Risk in Communities Study published in Circulation Feb. 4.

Serkan Kutan has been appointed chief technology officer to the healthcare joint venture between Amazon, Berkshire Hathaway and JPMorgan Chase & Co. The venture, still unnamed, was formed at the start of 2018.

Spending growth per Medicare beneficiary has slowed considerably since 2005, and 56 percent of that decline can be linked to reduced spending on cardiovascular disease and related risk factors, researchers reported Feb. 4 in Health Affairs.

A study investigating the differences between healthy brains and those with Alzheimer’s disease (AD) has produced a map of more than 24,000 AD-related datapoints, according to authors of the research published Feb. 4 in Communications Biology. They claim it is one of the largest datasets of its kind.

Effectively and accurately measuring the performance of diagnostic radiologists has been a significant challenge for many years now, a puzzle that specialists within the industry have yet to solve.

Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

AI for image analysis is predicted to be the top digital health technology for 2019 based on a survey of healthcare professionals, according to Forbes.

University of Arizona in Tuscon researchers, led by Diego Martin, MD, PhD, chair of the university’s medical imaging department, have developed an MRI technique aimed to replace blood tests and invasive biopsies for measuring nonalcoholic fatty liver disease, according to a report by the Arizona Daily Star.